微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | -2.32% | -1884.62% | -79.84% | 124/159 | 4.1% | 迪哲医药 | 115.44% | 行业排名> |
| 2026-06-30 | -1.29% | -13000% | -67.53% | 120/159 | 1.36% | 泽璟制药 | 44.02% | 行业排名> |
| 2026-03-31 | -0.77% | -3750% | -13.24% | 125/159 | 0.06% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-12-31 | -0.68% | -173.91% | -623.08% | 104/159 | -4.32% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-09-30 | 0.13% | -68.29% | 1200% | 107/159 | 1.69% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 0.01% | -91.67% | 150% | 109/159 | 0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | -0.02% | -116.67% | -102.17% | 112/159 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 0.92% | 135.52% | 124.39% | 98/159 | -9.4% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 0.41% | -89.95% | 241.67% | 109/159 | 4.26% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 0.12% | 105.24% | 0% | 113/159 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 0.12% | 102.73% | 104.63% | 113/159 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -2.59% | -859.26% | -163.48% | 111/159 | -0.94% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 4.08% | 138.42% | 278.17% | 79/159 | 2.36% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | -2.29% | 69.55% | 47.95% | 122/159 | 1.49% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | -4.4% | -104.65% | -1529.63% | 135/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -0.27% | -115.52% | 97.46% | 111/159 | 0.84% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | -10.62% | -1101.89% | -41.22% | 129/159 | 2.87% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | -7.52% | 10.16% | -249.77% | 136/159 | 2.21% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | -2.15% | -157.18% | -223.56% | 126/159 | 1.59% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 1.74% | -89.8% | 64.15% | 100/159 | 0.87% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 1.06% | -97.21% | 112.66% | 110/159 | 4.45% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | -8.37% | -135.71% | -322.61% | 134/159 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 3.76% | -78.95% | -77.96% | 26/159 | 2.48% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 17.06% | 104.43% | -55.11% | 29/159 | 3.82% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 38% | 222.9% | 62.12% | 2/159 | 3.15% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 23.44% | 414.63% | 31.24% | 2/159 | 4.28% | 中哲精化 | 45.32% | 行业排名> |
| 2020-03-31 | 17.86% | 971.22% | 104.63% | 2/159 | 2.23% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | -385.51% | -259.75% | -1146.8% | 134/159 | 2.62% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | -30.92% | -39.53% | -315.03% | 104/159 | 7.58% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | -7.45% | 54.21% | -263.41% | 111/159 | 5.02% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | -2.05% | 31.44% | 98.09% | 103/159 | 2.44% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | -107.16% | -9500% | -383.57% | 132/159 | 7.16% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | -22.16% | -2230.77% | -36.2% | 99/159 | 7.2% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | -16.27% | -2811.67% | -444.15% | 103/159 | 4.62% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | -2.99% | -49.5% | -362.28% | 97/159 | 2.57% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 1.14% | -76.05% | 9.62% | 112/159 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 1.04% | -73.06% | 73.33% | 90/159 | 8.3% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 0.6% | -85.15% | 130% | 95/159 | 5.55% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | -2% | -213.64% | -142.02% | 87/159 | 2.11% | 中哲精化 | 54.24% | 行业排名> |
| 2016-12-31 | 4.76% | -23.1% | 23.32% | 84/159 | 6.11% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 3.86% | 343.68% | -4.46% | 59/159 | 5.7% | ST南新 | 81.7% | 行业排名> |
| 2016-06-30 | 4.04% | 425.81% | 129.55% | 48/159 | 3.56% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 1.76% | 145.83% | -71.57% | 47/159 | 2.69% | 贝达药业 | 16.78% | 行业排名> |